GSK, Sanofi to provide 300 million doses of COVID-19 vaccine to EU Ruchika Sharma19 Sept 2020 1:15 PM ISTA Phase 3 study is planned to begin by the end of 2020 and regulatory approval could be requested in the first half of 2021.
GSK-Regional Centre for Biotechnology completes 1 year of academia-industry initiative Ruchika Sharma15 Sept 2020 12:26 PM ISTThe Trust in Science program offers full PhD courses in Biostatistics and Bioinformatics to equip Indian students for a career in a data and AI-driven...
GSK to launch New Advil Dual Action with Acetaminophen Farhat Nasim11 Sept 2020 9:45 AM ISTNew Delhi: GSK Consumer Healthcare recently announced the launch of new Advil Dual Action, an exclusive formula that combines two of the most powerful...
COVID-19: Pharma firms sign vaccine safety pledge MD Bureau9 Sept 2020 1:45 PM ISTThe CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer and Sanofi have signed the pledge.
Sanofi, GSK begin human trial of coronavirus vaccine candidate MD Bureau4 Sept 2020 10:00 AM ISTParis: Pharmaceutical giants Sanofi and Glaxo Smith Kline (GSK) on Thursday started a clinical trial for their jointly developed Covid-19 vaccine...
Combating COVID-19: GSK, Vir Biotechnology enter race to find antiviral drugs Medical Dialogues Bureau1 Sept 2020 9:45 AM ISTNew Delhi: GlaxoSmithKline and partner Vir Biotechnology have started testing their experimental antibody on early-stage COVID-19 patients, entering...
Industry leaders, Govt officials eye global collaboration in pharma sector Farhat Nasim31 Aug 2020 2:48 PM ISTNew Delhi: The need of global collaboration in the pharma sector from research and development to drug manufacturing has never been as great as it is...
US to put up $2.1 bn for Sanofi, GSK coronavirus vaccine Ruchika Sharma3 Aug 2020 9:45 AM ISTSanofi, based in France, and GSK of Britain said clinical trials with their vaccine should start in September, with a Phase 3 study under way by the...
Sanofi GSK to supply Britain with up to 60 million doses of a potential COVID-19 vaccine Ruchika Sharma30 July 2020 2:46 PM ISTBoth companies voiced in a statement their commitment " to making their COVID-19 vaccine candidate affordable and available globally".
EU talks with Pfizer, Sanofi, JnJ on Potential COVID Vaccines Struggle To Reach Deal: Report Ruchika Sharma29 July 2020 9:30 AM ISTMilan: European efforts to secure potential COVID-19 vaccines from Pfizer, Sanofi and Johnson & Johnson are mired in wrangles over price, payment...
Sanofi, GSK close to USD 624 million Vaccine supply Deal: Bloomberg Ruchika Sharma6 July 2020 12:00 PM ISTUK: GlaxoSmithKline and Sanofi are close to reaching a 500 million-pound ($624 million) deal to supply the U.K. government with 60 million doses of a...
AstraZeneca eyes three-drug inhaler opportunity after trial results Ruchika Sharma26 Jun 2020 9:15 AM ISTAstraZeneca said that the ETHOS trial of triple-drug therapy c formerly known as PT010, helped patients suffering from a chronic obstructive pulmonary...
